REGN
Regeneron Pharmaceuticals Inc
$974.88
1.29%
+12.44
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Loading
Key Stats
Market cap.
108.2B
Enterprise value
98.2B
Trailing PE
28.984655
Forward PE
20.519949
PEG Ratio
20.519949
Enterprise to EBITDA
22.185
Enterprise to revenue
7.493
Price to book MRQ
3.9268196
Price to sales TTM
8.262121
Financials
Fiscal Year Ends
2023-12-31
Most Recent Quarter (MRQ)
2024-03-31
Revenue (TTM)
13.1B
EBITDA
5B
Diluted EPS TTM
33.89
Total Cash (MRQ)
10.5B
Current ratio (MRQ)
5.27
Operating Cash Flow (TTM)
4.7B
